Aplastic Anemia News and Research

RSS
Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Alexion joins EURORDIS, NORD and medical communities to observe Rare Disease Day 2011

Alexion joins EURORDIS, NORD and medical communities to observe Rare Disease Day 2011

Prototype drug halts GVHD in mouse models of bone marrow transplantation

Prototype drug halts GVHD in mouse models of bone marrow transplantation

Quebec reimburses VIDAZA for treatment of blood cancer

Quebec reimburses VIDAZA for treatment of blood cancer

New analysis of Soliris in patients with PNH presented at ASH Annual Meeting

New analysis of Soliris in patients with PNH presented at ASH Annual Meeting

New analysis evaluates association between hemolysis, mortality in patients with PNH

New analysis evaluates association between hemolysis, mortality in patients with PNH

New data on Soliris for PNH treatment to be presented at ASH Annual Meeting

New data on Soliris for PNH treatment to be presented at ASH Annual Meeting

Sandoz initiates voluntary recall of Methotrexate Injection

Sandoz initiates voluntary recall of Methotrexate Injection

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

UCB presents P3, P4 clinical trial data for Crohn's disease at ACG Scientific Meeting

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

ACG meeting to exhibit Cimzia data for Crohn's disease treatment

Dr. Bessler joins Children's Hospital of Philadelphia

Dr. Bessler joins Children's Hospital of Philadelphia

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Telomere length associated with higher rate of relapse and lower overall survival in aplastic anemia patients

Telomere length associated with higher rate of relapse and lower overall survival in aplastic anemia patients

Hematopoietic cell transplantation survivors report of  chronic health condition after procedure

Hematopoietic cell transplantation survivors report of chronic health condition after procedure

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

U.S. clinical trials provide further evidence of importance of storing umbilical cord blood

U.S. clinical trials provide further evidence of importance of storing umbilical cord blood

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

New research evaluating substantial disease burden of PNH presented at European Hematology Association

New research evaluating substantial disease burden of PNH presented at European Hematology Association

Platelet dosage can be lowered in transfusions for cancer and bone-marrow transplant patients

Platelet dosage can be lowered in transfusions for cancer and bone-marrow transplant patients